Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Reducing Stroke Associated Pneumonia and Urinary Tract Infection
NCT05375240Phase 2Unknown
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in pneumonia, urinary tract infection (UTI), sponsored by Tianjin Medical University General Hospital. Status: unknown.
02
Drugs
propranolol
03
Conditions
pneumoniaurinary tract infection (UTI)
Beyond the preview
Go deeper on NCT05375240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05375240.